EichorEICHOR
Condition: Head And Neck Disorder Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Head And Neck Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of Postbiotics on Microbiota and Systemic Immunomodulation of Pembrolizumab as First-Line Therapy in Recurrent/Me
Phase 2 · 1 location(s) · Gruppo Oncologico del Nord-Ovest · NCT07485296Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic On
Phase 2 · 2 location(s) · Fudan University · NCT05281003Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma
Phase 2/Phase 3 · 1 location(s) · Peking Union Medical College Hospital · NCT06907602Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Phase 1/Phase 2 · 9 location(s) · Sichuan Enray Pharmaceutical Sciences Company · NCT07433283Enhancing Oral Cancer Awareness
NA · 1 location(s) · Virginia Commonwealth University · NCT06682494Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma
NA · 1 location(s) · Ruijin Hospital · NCT06596954Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy
Phase 2 · 1 location(s) · Xijing Hospital · NCT06586242Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
Phase 4 · 1 location(s) · Indiana University · NCT06982105Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC
Phase 3 · 7 location(s) · Eye & ENT Hospital of Fudan University · NCT06235203IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
Phase 3 · 3 location(s) · Sun Yat-sen University · NCT05941741Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT
Phase 2 · 1 location(s) · Fudan University · NCT05628922Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT04136886Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal
Phase N/A · 1 location(s) · Anhui Provincial Hospital · NCT05833594A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combin
Phase 1 · 1 location(s) · Anhui Provincial Hospital · NCT06232083CONFIRM: Magnetic Resonance Guided Radiation Therapy
NA · 2 location(s) · Brigham and Women's Hospital · NCT04368702A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06190639Study of XB010 in Subjects With Solid Tumors
Phase 1 · 20 location(s) · Exelixis · NCT06545331"Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON)
NA · 1 location(s) · University of Pisa · NCT06336941Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05800054Telemedicine Follow-Up for Early Laryngeal Cancer: a Randomized Controlled Trial Comparing Care Close to Home Versus Sta
NA · 1 location(s) · University Medical Center Groningen · NCT06940505Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients
NA · 1 location(s) · Mucosa Innovations, S.L. · NCT05635929Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)
Phase N/A · 1 location(s) · National Cancer Institute, Naples · NCT06905262Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
Phase 4 · 1 location(s) · Cedars-Sinai Medical Center · NCT07124351Upfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cancers:
Phase 3 · 7 location(s) · All India Institute of Medical Sciences, Jodhpur · NCT06737822A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerabili
Phase 1/Phase 2 · 10 location(s) · Lumara Bio Oncologics GmbH · NCT05706129Morphological Changes of Upper Trapezius Muscle After Physotherapy in Oral Cancer
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT07166575F-18 Tetrafluoroborate PET/CT in Differentiated Thyroid Cancer
NA · 2 location(s) · Ankara University · NCT07436455Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
Phase 3 · 5 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT04821778Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
Phase 2 · 2 location(s) · Peking Union Medical College · NCT06145308A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · 62 location(s) · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.